JAZZ - Jazz Pharmaceuticals plc

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 110.01

Open

$ 110.02

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 108.77 - $ 111.46

52 Week Range

$ 103.01 - $ 146.70

Volume

693,769

Average Volume

Market Cap

6.88B

Beta (5Y Monthly)

$ 0.70

PE Ratio (TTM)

$ 20.80

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	08-03-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	02-23-2021	12-31-2020	10-K
15	11-02-2020	09-30-2020	10-Q
16	08-04-2020	06-30-2020	10-Q
17	05-05-2020	03-31-2020	10-Q
18	02-25-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	02-26-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	02-27-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	02-28-2017	12-31-2016	10-K
31	11-08-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	02-23-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-05-2015	06-30-2015	10-Q
37	05-07-2015	03-31-2015	10-Q
38	02-24-2015	12-31-2014	10-K
39	11-04-2014	09-30-2014	10-Q
40	08-05-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Jazz...
05/03/2024 19:22:26

HC Wainwright & Co. analyst Oren Livnat reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $200 pric...

Barclays Maintains Overweight on Jazz Phar...
05/03/2024 14:30:33

Barclays analyst Balaji Prasad maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and lowers the price target fr...

Demystifying Jazz Pharmaceuticals: Insight...
05/02/2024 14:00:36

Needham Reiterates Buy on Jazz Pharmaceuti...
05/02/2024 10:35:13

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $222 price target.

Jazz Pharmaceuticals Affirms 2024 Revenue ...
05/01/2024 21:08:45

Jazz Pharmaceuticals Q1 2024 Adj EPS $2.68...
05/01/2024 21:08:07

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported quarterly earnings of $2.68 per share which missed the analyst consensus estimate o...

Breaking Down Jazz Pharmaceuticals: 15 Ana...
04/10/2024 14:01:22

Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 13:37:31

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $180 ...

CORRECTION: Jazz Pharmaceuticals Completes...
04/02/2024 12:00:28

how-to-make-your-cannabis-business-more-attractive-for-investors-in-2024-advice-on-financial-health--innovation

How To Make Your Cannabis Business More At...
03/25/2024 13:39:44

Cantor Fitzgerald Reiterates Overweight on...
03/22/2024 17:49:30

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $180 ...

Truist Securities Reiterates Buy on Jazz P...
03/20/2024 15:50:21

Truist Securities analyst Joon Lee reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $200 price target.

The Analyst Landscape: 12 Takes On Jazz Ph...
03/20/2024 14:00:45

Piper Sandler Reiterates Overweight on Jaz...
03/20/2024 12:31:21

Piper Sandler analyst David Amsellem reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price ta...

Piper Sandler Maintains Overweight on Jazz...
03/20/2024 11:58:25

Piper Sandler analyst David Amsellem maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price tar...

Needham Reiterates Buy on Jazz Pharmaceuti...
03/20/2024 10:39:43

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $220 price target.

Stifel Maintains Buy on Jazz Pharmaceutica...
03/15/2024 13:37:47

Stifel analyst Annabel Samimy maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $225 ...

HC Wainwright & Co. Maintains Buy Rating f...
03/14/2024 17:00:21

HC Wainwright & Co. Maintains Buy on Jazz ...
03/14/2024 11:28:57

HC Wainwright & Co. analyst Oren Livnat maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price tar...

CORRECTION: Jury Ruled In Favor Of Avadel ...
03/04/2024 20:52:24